Belay Diagnostics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Illinois, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1375 W Fulton St Ste 530, Chicago, Illin...Website
www.belaydiagnostics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Belay Diagnostics
Belay Diagnostics provides next-gen sequencing to detect aneuploidy and mutations with the company's cerebrospinal fluid testing platform. Improving diagnosis for brain and spinal cord cancers can give people the best chance for a cure without the need for invasive biopsies. The company see the company's technological advances in cerebrospinal fluid assays as offering clinicians alternative diagnostic tools for use in treatment decisions.Explore more
Belay Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Belay Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Belay Diagnostics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Belay Diagnostics
Funding: Get notified immidiatlly once Belay Diagnostics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Belay Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Belay Diagnostics is spiking on competitors!
Check if Belay Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Belay Diagnostics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Belay Diagnostics launches new products
Recommended Actions
Find VP level buyers at Belay Diagnostics
Find 2 more new buyers
Compare Similar Companies to Belay Diagnostics
Compare insights from companies similar to Belay Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Belay Diagnostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Belay Diagnostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Belay Diagnostics.
Belay Diagnostics Tech Stack
A closer look at the technologies used by Belay Diagnostics
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Facilities Relocation / Expansion
Belay Diagnostics is planning to move offices in March 2025. The move will impact approximately 15 employees at the existing office located at 1375 W. Fulton St., Suite #530, Chicago, IL.
Facilities Relocation/Expansion
Funding
Project
Spending/Investment, Funding
Open Position
Belay Diagnostics News & Media
Belay Diagnostics Reports 82% Clinical Impact Rate for Summit™ and Vantage™ in CNS Lymphoma Study
CHICAGO, March 24, 2026 /PRNewswire/ -- Belay Diagnostics announced the publication of a new retrospective study demonstrating that its Summit and Vantage tests provided meaningful clinical impact in 82% of CNS lymphoma cases evaluated. The study, which analyzed 50 specimens from 48...GenomOncology Announces Strategic Partnership with WeTrials to Accelerate Clinical Trial Enrollment for CNS Cancer Patients
CLEVELAND, March 10, 2026 /PRNewswire/ -- GenomOncology, a leading precision medicine software company, today announced a strategic partnership with WeTrials, an AI-powered patient engagement and trial enablement platform, to help CNS cancer patients access and enroll in clinical trials...Belay Diagnostics Announces the Validation of Summit™ 2.0 Comprehensive Genomic Profile Assay in Cerebrospinal Fluid (CSF)
Validation Data on 118 Patients Published in Cancers CHICAGO, Feb. 18, 2026 /PRNewswire/ -- Belay Diagnostics, an innovative CLIA/CAP accredited laboratory focused on the development and commercialization of molecular diagnostics targeting central nervous system (CNS) cancers, announced...The End Brain Cancer Initiative Partners with Belay Diagnostics to Raise Awareness of Diagnostic Testing for CNS Tumors
REDMOND, WA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- The End Brain Cancer Initiative Partners with Belay Diagnostics to Raise Awareness of Diagnostic Testing for CNS Tumors The End Brain Cancer Initiative (EBCI) has partnered with Belay …
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Belay Diagnostics
Sign Up For FreeTo access detailed company insights
Belay Diagnostics provides next-gen sequencing to detect aneuploidy and mutations with the company's cerebrospinal fluid testing platform. Improving diagnosis for brain and spinal cord cancers can give people the best chance for a cure without the need for invasive biopsies. The company see the company's technological advances in cerebrospinal flui... Read More
